—
LONDON, March 24LONDON, March 24 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the European Remote Patient Monitoring Market to be held on Tuesday, 31st March 2009, at 2 p.m. GMT.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
The world is facing an ongoing healthcare crisis along with the global economic slowdown. The timing could not be any worse: mounting costs, a steady increase regarding the ageing population, dysfunctional reimbursement policies, limited access, an ever impending physician shortage and concerns over quality of care are just some of the concerns.
In times like these, the focus should move to promising new technologies, which hold a lot of potential. Remote patient monitoring technologies are increasingly being recognized as valuable tools for enhancing quality care in chronic disease management. They have the potential to deliver new and unimaginable savings for both patients and providers. Unfortunately though, consumers remain woefully ignorant of the performance ability of these technologies, even though they could help them not only improve their health, but also manage it.
Highlights of the Frost & Sullivan briefing include the discussion of: current trends, challenges, drivers and restraints, significant market developments, revenue forecasts and a look on to the road ahead. The briefing will benefit service providers, equipment vendors, distributors and physicians by discussing various factors influencing the market and highlighting the emerging trends.
"The heightened demands of an ageing population and a related increase in chronic diseases are helping the remote patient monitoring market growth. It has the potential to change the way patients manage their own condition, so that they become the managers of their own health," notes Senior Research Analyst Janani Narasimhan. "Innovative and advanced technology continues to play a significant role in the RPM market. New technologies are constantly changing to support better healthcare services, while steadily improving patient monitoring capabilities."
Frost & Sullivan will hold this conference call at 2 p.m. GMT on Tuesday, 31st March 2009, which will provide industry participants an outlook of the European Remote Patient Monitoring Market. To participate, please email Katja Feick at katja.feick@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you.
GIL 2009: Europe
Frost & Sullivan has expanded its flagship Global Congress on Corporate Growth - GIL Global - into several major cities around the world including London. For the first time ever in Europe, Frost & Sullivan will be hosting the Growth, Innovation and Leadership Congress 'GIL 2009: Europe' on 19-20 May, at the Sofitel St James in London. GIL Global is the industry's only event designed to support senior executives in their efforts to achieve sustainable, top-line growth. To register, obtain a programme agenda, explore sponsorship opportunities, or attend as a member of the media for GIL 2009: Europe, please contact Katja Feick, Corporate Communications Europe, at katja.feick@frost.com. One-on-One interviews with Frost & Sullivan senior growth consultants are also being scheduled. For more information you can also visit http://www.frost.com/gilglobal
About Frost & Sullivan:
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com/
Contact: Katja Feick Corporate Communications - Europe P: +49-(0)-69-77-0-33-43 F: +49-(0)-69-23-45-66 E: katja.feick@frost.com www.frost.com
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
